Next Article in Journal
Preparation of a Titania/X-Zeolite/Porous Glass Composite Photocatalyst Using Hydrothermal and Drop Coating Processes
Next Article in Special Issue
Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents
Previous Article in Journal
Soy Isoflavones in Nutritionally Relevant Amounts Have Varied Nutrigenomic Effects on Adipose Tissue
Previous Article in Special Issue
Synthesis and Biological Evaluation of Novel 6-Hydroxy-benzo[d][1,3]oxathiol-2-one Schiff Bases as Potential Anticancer Agents

Targeting Carbonic Anhydrase IX Activity and Expression

Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, FL 32611, USA
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editor: Jean Jacques Vanden Eynde
Molecules 2015, 20(2), 2323-2348;
Received: 18 August 2014 / Accepted: 25 December 2014 / Published: 30 January 2015
Metastatic tumors are often hypoxic exhibiting a decrease in extracellular pH (~6.5) due to a metabolic transition described by the Warburg Effect. This shift in tumor cell metabolism alters the tumor milieu inducing tumor cell proliferation, angiogenesis, cell motility, invasiveness, and often resistance to common anti-cancer treatments; hence hindering treatment of aggressive cancers. As a result, tumors exhibiting this phenotype are directly associated with poor prognosis and decreased survival rates in cancer patients. A key component to this tumor microenvironment is carbonic anhydrase IX (CA IX). Knockdown of CA IX expression or inhibition of its activity has been shown to reduce primary tumor growth, tumor proliferation, and also decrease tumor resistance to conventional anti-cancer therapies. As such several approaches have been taken to target CA IX in tumors via small-molecule, anti-body, and RNAi delivery systems. Here we will review recent developments that have exploited these approaches and provide our thoughts for future directions of CA IX targeting for the treatment of cancer. View Full-Text
Keywords: carbonic anhydrase IX; tumor hypoxia; prodrug; sulfonamide; RNAi-technology; cancer carbonic anhydrase IX; tumor hypoxia; prodrug; sulfonamide; RNAi-technology; cancer
Show Figures

Graphical abstract

MDPI and ACS Style

Mahon, B.P.; Pinard, M.A.; McKenna, R. Targeting Carbonic Anhydrase IX Activity and Expression. Molecules 2015, 20, 2323-2348.

AMA Style

Mahon BP, Pinard MA, McKenna R. Targeting Carbonic Anhydrase IX Activity and Expression. Molecules. 2015; 20(2):2323-2348.

Chicago/Turabian Style

Mahon, Brian P., Melissa A. Pinard, and Robert McKenna. 2015. "Targeting Carbonic Anhydrase IX Activity and Expression" Molecules 20, no. 2: 2323-2348.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop